Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
2,299.00
+544.00 (31.00%)
Mar 4, 2026, 5:31 PM IDT
-37.01%
Market Cap 18.44M
Revenue (ttm) 34.95M
Net Income (ttm) -40.10M
Shares Out 849.65K
EPS (ttm) -47.90
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9,224
Average Volume 1,808
Open 1,755.00
Previous Close 1,755.00
Day's Range 1,755.00 - 2,459.00
52-Week Range 1,703.00 - 4,400.00
Beta 0.83
RSI 49.21
Earnings Date Mar 30, 2026

About TLV:TKUN

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers clinical research, training, and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd was founded in 2006 and is based in Nof HaGalil, Israel. [Read more]

Sector Healthcare
Founded 2006
Employees 19
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol TKUN
Full Company Profile

Financial Performance

In 2024, TLV:TKUN's revenue was 34.95 million, a decrease of -20.97% compared to the previous year's 44.23 million. Losses were -40.10 million, -54.88% less than in 2023.

Financial Statements

News

There is no news available yet.